Literature DB >> 27547120

Olanzapine Induced Dilated Cardiomyopathy.

Beeresha Puttegowda1, Joseph Theodore1, Ramesh Basappa1, Manjunath Cholenally Nanjappa1.   

Abstract

A 28-year-old male patient with bipolar disorder taking olanzapine and lorazepam for almost 10 years presented with weight gain, diabetes, and anasarca was examined in this study. Evaluation of the patient revealed he was in heart failure. The reason for his heart failure was ambiguous and an investigation into it revealed negative results. Literature search conducted showed a few reported cases of putative olanzapine induced cardiomyopathy. One such relatively rare case is presented here.

Entities:  

Keywords:  antipsychotics; cardiomyopathy; etiology; heart failure; olanzapine

Year:  2016        PMID： 27547120      PMCID： PMC4976704     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN： 1394-195X


  7 in total

1.  Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study.

Authors:  D M Coulter; A Bate; R H Meyboom; M Lindquist; I R Edwards
Journal:  BMJ       Date:  2001-05-19

2.  Serum levels of eosinophil cationic protein in patients with eosinophilic myocarditis.

Authors:  Mizuhiro Arima; Tatsuji Kanoh; Yasunobu Kawano; Tetsuya Oigawa; Shinichiro Yamagami; Shigeru Matsuda
Journal:  Int J Cardiol       Date:  2002-07       Impact factor: 4.164

3.  Adolescent with treatment-refractory schizophrenia and clozapine-induced cardiomyopathy managed with high-dose olanzapine.

Authors:  Vanessa Toney Bobb; L Fredrik Jarskog; Barbara J Coffey
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-12       Impact factor: 2.576

4.  Cardiac lesions induced by neuroleptic drugs in the rabbit.

Authors:  D Belhani; D Frassati; R Mégard; P Tsibiribi; B Bui-Xuan; A Tabib; L Fanton; D Malicier; J Descotes; Q Timour
Journal:  Exp Toxicol Pathol       Date:  2005-11-15

5.  Drugs and dilated cardiomyopathies: A case/noncase study in the French PharmacoVigilance Database.

Authors:  Guillaume Montastruc; Sylvie Favreliere; Agnès Sommet; Atul Pathak; Maryse Lapeyre-Mestre; Marie-Christine Perault-Pochat; Jean-Louis Montastruc
Journal:  Br J Clin Pharmacol       Date:  2010-03       Impact factor: 4.335

6.  Incidence of cardiovascular outcomes and diabetes mellitus among users of second-generation antipsychotics.

Authors:  Leslie Citrome; Jenna M Collins; Beth L Nordstrom; Edward J Rosen; Ross Baker; Anagha Nadkarni; Iftekhar Kalsekar
Journal:  J Clin Psychiatry       Date:  2013-12       Impact factor: 4.384

7.  Severe cardiovascular side effects of olanzapine in an elderly patient: case report.

Authors:  Tien-Wen Lee; Shi-Jen Tsai; Jen-Ping Hwang
Journal:  Int J Psychiatry Med       Date:  2003       Impact factor: 1.210
  7 in total
  2 in total

1.  Characteristics and Spectrum of Cardiotoxicity Induced by Various Antipsychotics: A Real-World Study From 2015 to 2020 Based on FAERS.

Authors:  Luyao He; Yimin Yu; Yumei Wei; Jingjing Huang; Yifeng Shen; Huafang Li
Journal:  Front Pharmacol       Date:  2022-02-04       Impact factor: 5.810

2.  Molecular studies in familial dilated cardiomyopathy - A pilot study.

Authors:  Vyom Mori; J P S Sawhney; I C Verma; Ashwani Mehta; Renu Saxena; Rajiv Passey; Arun Mohanty; Bhuwanesh Kandpal; B S Vivek; Manish Sharma; Ashish Kumar Jain; Dipak Katare
Journal:  Int J Cardiol Heart Vasc       Date:  2022-04-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.